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newborn pig by preventing the development of hypo
METHOD FOR IMPROVING THE METABOLIC
STABILITY AND SURVIVAL OF NEWBORN PIGS

BACKGROUND AND SUMMARY OF THE
INVENTION

glycemia in the neonatal pig shortly after birth.
Still another object of the present invention is to
provide a food supplement which is effective in elevat
5

‘

ing the ketone levels in blood of the pregnant pig.
Other subjects and further scope of applicability of
the present invention is to provide a food supplement
which is effective in elevating the ketone levels in blood

The present invention relates to an improved method

for increasing the survival rate of baby pigs. More par
ticularly, the present invention is directed to a method

of the pregnant pig.

of increasing the survival rate of baby pigs by using a
food supplement in the diet of a pregnant pig.

Other objects and further scope of applicability of the
present invention will become apparent from the de

The low survival rate observed in baby pigs, e. g., 20

tailed description given hereinafter. However, it should
be understood that the detailed description and speci?c

to 30% mortality between birth and weaning, is attrib

examples, While indicating preferred embodiments of
(1) the high degree of metabolic immaturity in the 15 the invention, are given by way of illustration only,
since various changes and modi?cations within the
newborn pig and
uted largely to two factors:

spirit and scope of the invention will become apparent
to those skilled in the art from this detailed description.
Pursuant to the present invention, it has been found
that the administration of speci?c alcohols and glycer
ides to female pigs during late stages of gestation effec
tively increases the liver glycogen stores in the pig at
birth and prolongs the availability of the liver glycogen
stores in the newborn pig. This increased availability of

(2) an insufficient energy intake by the pig in its ?rst
2 or 3 days of life.

The magnitude of this loss can be emphasized by the
fact that 'each 1% improvement in pig survival will
generate an additional $4.00 to $7.00 pro?t per litter.
The major metabolic defects observed in the new
born pig are summarized as follows:

.

1'. A low level of phosphorylase potentially decreases
the rate of production of glucose from glycogen stores;

glycogen delays the onset of hypoglycemia in the pig

2. A defective gluconeogenic capacity limits the sup
ply of glucose available to animals exposed to stress;
3. A de?cient hepatic mitochondria number limits the

and increases the survival rate (percent of pigs born
alive that survive to weaning) of neonatal pigs.

use of carbohydrates as well as fatty acids for energy

present invention include dihydroxy alkanols having 3

production;

to 10 carbon atoms and the mono- and diesters of such

The alcohols which can be used according to the

4. A small amount of body fat impairs both thermoin

diols and fatty acids containing 8—12 carbon atoms, such

sulation and the quantitative contribution of fat as a

as for example, 1,3-butanediol monooctanoate. The

major energy source; and

preferred alkanol is 1,3-butanediol.

'

The glycerides which can be used in the present in

5. A defective amino metabolismv tends to limit a

source of substrate (carbon skeletons) for gluconeogen

vention include the medium chain length triglycerides

esis.

such as for example the reaction product of glycerol
and fatty acids containing 8 to 12 carbon atoms.

More speci?cally, the high mortality rate observed in
pigs is attributed largely to the newborn pigs impaired

The alkanols and the glycerides are administered to

thermostability and defective gluconeogenic capacity

40 the pregnant pig as a food supplement, for example, as

and its inability to obtain a suf?cient energy intake from
the sow’s milk during its ?rst 2 or 3 days of life. Because
of these major metabolic defects, as well as the others

an addition to a corn-soybean meal diet. The alkanol

supplement, for example, 1,3-Butanediol, which is a
ketone former, has been found to be palatable and ef?
set forth hereinabove, particularly. its low gluconeo
ciently utilized by the pig when included as a food
genic capacity, the neonatal pig rapidly develops hypo 45 supplement to provide about .6 to 20% of the dietary
glycemia after birth if not permitted to suckle or if
energy in the pigs diet as shown in the following table:
subject to cold stress.

'

This rapid onset of hypoglycemia in the newborn pig

TABLE 2

is the result of 95% of the pig’s energy reserves in the
form of glycogen being used within the ?rst 72 hours of
birth regardless of whether the pig is suckled or not by

1,3-Butanediol Supplementation in Growing Swine.
1,3-Butanediol, % of dietary energy

the sow. The signi?cance of the baby pig’s susceptibility

Trait

to hypoglycemia is indicated by the 30 to 50% death
loss observed within 72 hours after birth when baby

Wt. gain, kg
ME intake, Mcal

6 hours after birth and then fasted.
Research has been conducted to identify factors

B-hydroxybutyrate,
nmole/ml
Acetoacetate, nmole/ml

ME/wt gain, Meal/kg
pigs are fasted from birth or when baby pigs are fed for 55 Plasma

which would reduce baby pig mortaility. These investi
gations have suggested that the existence of physiolog

Glucose, mg/dl

0

8

17

25

33

42

19.5
197

20.5
212

21.4
219

11.9
157

4.3
85

1.1
77

' 10.1

10.3

10.2

13.2

19.8

70.0

159

415

457

425

831

980

69
75

100
72

115
95

183
97

150
142

198
119

ical conditions, i.e., diabetes, starvation, high dietary fat
As can be seen from the table, higher dietary levels of

intake, etc., which are associated with elevated blood
ketone levels in the sow, may result in heavier, more

1,3-Butanediol, e.g., greater than 25% of the dietary

metabolically stable pigs at birth.

energy, tend to depress feed consumption and subse

quent growth.

Accordingly, an object of the present invention is to

provide an improved method for increasing the survival
rate of baby pigs.
A further object of the present invention is to provide
a method for improving the metabolic stability of the

65

Because ketones have shown to be readily transferred
across the placenta, 1,3-Butanediol, a ketone former,
represents a potential ‘supplemental’ energy source for

the developing fetus.

4,329,359
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According to the present invention, it has been found

4

higher percent fat than that of sows fed the control diet

(table 5).

that a short-term administration of 1,3-Butanediol in
sows during late gestation results in an increased liver

TABLE 4

glycogen content in the newborn pig and an improved

Effect on 1,3-Butanediol Supplementation in Sows During Late

pig survival from birth to weaning. Advantageously,
the administration of the speci?c food additive of the

Gestation on Plasma Glucose and Liver Glycogen Stores

in Neonatal Pigs.”

present invention can begin about 4 to 12 days, advanta

Age of
Pig, hr

geously about 9 days, before parturition and continue

Feeding
Regime

Prepartum Treatment”
Control
1,3-Butanediol
Liver glycogen, mg

until parturition. After parturition, the sows are ‘allowed
10

to consume a standard lactation diet.

The following example is provided as being exem
plary of the present invention and should not be consid
ered as being limitative of the present invention.
EXAMPLE
Sixty-eight sows were fed isocaloric intakes (6000
kcal of metabolizable energy/sow/day) of a forti?ed
corn-soybean meal diet plus an additional 1600 kcal of
metabolizable energy in the form of starch or 1,3

.70

12

Fasted

.48

o

_

137.6

122.7

12
12

Nursed
Fasted

92.7
84.7

124.2
93.8

' Gestation on the Fat and Protein Content of Sow’s Colostrum.“

~

Hr Postpartum

At birth

Control

25~
0
12

2.7
3.1

O
12

13.8
10.5

Prepartum Treatment“
1,3-Butanediol
Colostrum fat, %
4.3
3.9

Colostrum protein, %

Control

1,3-butanediol

Change

10.39

10.14

8.79

9.28

+.49

respectively.

1.20

1.26

+06

3.51
85.30
11.10

3.58
92.00
16.20

+.08
+6.7

What is claimed:
1. A method of treating a pregnant sow to improve
the metabolic stability of newborn pigs and to increase

Pigs/litter

At weaning
Pig Survival, %
Liver Glycogen, %

.96

TABLE 5

Prepartum Treatment“

At weaning
_ Avg. Pig Wt. (kg)

.85
-

Effect of 1,3-Butanediol Supplementation in Sows During Late

1,3-Butanediol Supplementation in Sows During Late Gestation.”

At birth

4.30

"Thirty and 42 pigs represented in the control and 1,3-Butanediol treatments,

turition. After parturition, all sows were allowed to
consume a standard lactation diet ad libitum. The results

Trait

3.47

respectively.

Butanediol beginning approximately 8 days before par

TABLE 3

—

Nursed

Blood glucose, mg/dl
15

are shown in the following table:

0

12

+5.1

15.1
10.5

"Ten and fourteen sows represented in the control and 1,3-Butanediol treatments,

35

“Thirty-eight and 40 litters represented in the control and 1,3-butanediol treatments,

the survival rate of said newborn pigs which comprise

respectively.

administering to the pregnant sow during its late stages
of gestation an effective amount of a material selected

As can be seen from the above table, the 1,3
from the group consisting of a dihydroxy alkanol hav
Butanediol supplementation did not influence the num 40 ing' 3 to 10 carbon atoms, a triglyceride of glycerol and
ber of live pigs born/litter (10.14 vs 10.39) or the aver
fatty acids containing 8 to 12 carbon atoms and the
mono- and diol esters of said alkanols and said fatty
age pig weights (g) at birth (1,259 vs 1,205) or at wean

ing (3575 vs 3510) compared to those of litters from
sows fed starch. However, 1,3-Butanediol supplementa
tion did increase liver glycogen levels in the newborn
pig (16.2 vs 11.1%) and did increase the total number of
pigs weaned/litter (9.28 vs 8.79) and the percent of pigs

acids.

'

2. The method of claim 1 wherein the dihydroxy
alkanol is 1,3-butanediol.
3. The method of claim 1 wherein the alkanol, the
triglyceride or the diol ester of said alkanols and fatty

born alive (92.0 vs 85.3) that survived to weaning com
acids are added as a food supplement to the sow’s diet.
pared to those of the starch treatment group. Sow feed
4. The method of claim 3 wherein the alkanol, the
intake and weight gain during lactation were not af 50 triglyceride or the diol ester of said alkanols and fatty

fected by dietary treatment.

acids are added in an amount sufficient to provide about

In a second experiment, the addition of 1,3
Butanediol to the diet of sows during late gestation was
shown to increase the metabolic stability of the new
cemia in pigs which were allowed to nurse or were

6 to 20% of the dietary energy in the sow’s diet.
5. The method of claim 1 wherein the alkanol, the
triglyceride and the diol esters of said alkanols and fatty
acids are administered about 4 to 12 days before parturi
tion and continued until parturition.
6. The method of claim 1 wherein the diester is 1,3

fasted from birth to 12 hr of age (table 4). In addition,

butanediol monooctanoate.

born pig by increasing the level of liver glycogen pres
ent in the pig at birth and delaying the onset of hypogly

*

the colostrum of sows fed 1,3-Butanediol contained a
60

65
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